Spago Nanomedical AB
A clinical-stage company developing nanomedicine for cancer diagnosis and treatment.
SPAGO | ST
Overview
Corporate Details
- ISIN(s):
- SE0004899474 (+2 more)
- LEI:
- 549300DNLTVJ4OGO5X40
- Country:
- Sweden
- Address:
- Scheelevägen 22, 223 63 Lund
- Website:
- https://spagonanomedical.se/
- Sector:
- Manufacturing
Description
Spago Nanomedical AB is a clinical-stage company specializing in nanomedicine for the diagnosis and treatment of cancer. The company's development is centered on a proprietary platform of polymeric nanomaterials designed to accumulate in tumor tissue, enabling targeted medical applications. Its portfolio includes two primary projects. The first, SpagoPix (SN132D), is a gadolinium-free contrast agent for magnetic resonance imaging (MRI) aimed at improving the visualization of solid tumors. The second project, Tumorad (177Lu-SN201), is a radionuclide therapy that utilizes the same nanomaterial platform to deliver a therapeutic radioisotope directly to cancer cells, offering a targeted treatment approach intended to minimize damage to healthy tissue.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Spago Nanomedical AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Spago Nanomedical AB
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Spago Nanomedical AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
